# Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand

> **NCT00006327** · PHASE3 · COMPLETED · sponsor: **VaxGen** · enrollment: 2500 (—)

## Conditions studied

- HIV Infections
- HIV Seronegativity

## Interventions

- **BIOLOGICAL:** MN rgp120/HIV-1 and A244 rgp120/HIV-1

## Key facts

- **NCT ID:** NCT00006327
- **Lead sponsor:** VaxGen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** —
- **Final completion:** 2000-08
- **Target enrollment:** 2500 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006327, "Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00006327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*